Path 3: Telomere Attrition

Rationale: The ticking clock of cell division limits. Each time a cell divides, the protective telomeres at chromosome ends shorten (except in germ cells and stem cells with telomerase). Eventually, telomeres erode to a critical length, triggering cell senescence or death. Shortened telomeres in the elderly and in chronic stress correlate with age-related diseases. Certain premature aging diseases are caused by mutations in telomerase or telomere-binding proteins.

Prerequisites: Cell biology (cell cycle, senescence), telomere biology (telomerase, shelterin complex).

Dependencies: Intersects with Path 8 (Cellular Senescence) – telomere shortening is one trigger for senescent cells. Also relates to Path 2 (DNA damage).

Signs of Progress: Safe telomerase therapies that extend cell lifespan without cancerous transformation. Telomerase gene therapy in adult mice that lengthened telomeres and improved tissue function. Development of telomere-extending drugs. Robust evidence that average telomere length in key tissues can be maintained or restored to youthful levels.

BC3.1: Telomere Biology and the Hayflick Limit

Scope: Understand what telomeres are and why they shorten. Cover Hayflick’s discovery of finite cell division capacity. Explain how telomerase extends telomeres.

• Blackburn, Elizabeth et al. “Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging.” Nat. Med., 2006. – Nobel laureate Blackburn gives a historical and scientific overview.
• Campisi, Judith & d’Adda di Fagagna, F. “Cellular senescence: when bad things happen to good cells.” Nat. Rev. Mol. Cell Biol., 2007. – Sections explaining replicative senescence due to telomeres.
• Hayflick, Leonard. “Biological aging is no longer an unsolved problem.” Ann. NY Acad. Sci., 2007. – Hayflick’s own perspective piece arguing cellular senescence is central to aging.

BC3.2: Telomeres in Aging and Disease

Scope: Evidence that telomere shortening contributes to organismal aging. Human data: leukocyte telomere length as a biomarker. Telomeropathies.

• Armanios, Mary & Blackburn, E. “The telomere syndromes.” Nat. Rev. Genet., 2012. – Excellent review of human telomere-related disorders.
• Jaskelioff, M. et al. “Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice.” Nature, 2011. – Direct evidence that telomere loss causes degeneration and restoring telomeres can reverse it.
• de Jesus, B.B. & Blasco, M.A. “Telomerase at the intersection of cancer and aging.” Cell, 2012. – Double-edged sword: telomere shortening causes aging and is a barrier to cancer.

BC3.3: Interventions – Telomerase, Lifestyle, and Drugs

Scope: Telomerase gene therapy, activator compounds, lifestyle factors. Evaluate safety issues.

• Feng, J. et al. “The telomerase inhibitor imetelstat rapidly accelerates short telomere-driven aging in mice.” Aging Cell, 2018. – Lack of telomerase can hasten aging.
• Simons, M.J.P. “Questioning causal involvement of telomeres in aging.” Ageing Res. Rev., 2015. – Critical review: are short telomeres a cause or just a marker?
• Fisher, K. & Hare, J. “Replication restart: Telomerase therapeutics in the pipeline.” Trends Mol. Med., 2017. – Telomerase-based therapies under development.

BC3.4: Measuring Telomeres and Modeling Their Impact

Scope: How to measure telomere length and model telomere dynamics.

• Kreibich, C. & Ferrié, M. “Lab Manual: Telomere Length Analysis Techniques.” Chapter in Methods in Molecular Biology, 2019. – Details techniques like quantitative PCR for telomere length.
• Aviv, A. & Shay, J.W. “Reflections on telomere dynamics and aging-related diseases.” Philos. Trans. R. Soc. B, 2018. – Interpreting telomere length data and pitfalls.
• Miller, O.J. “Telomeres: mathematical models of replicative senescence.” J. Theor. Biol., 2001. – Modeling cell population dynamics with telomere shortening.

Bibliography (Path 3)

• Blackburn, Elizabeth H. “Telomeres and Telomerase: The Means to the End.” Angew. Chem. Int. Ed. 49(41): 7405–7421, 2010. (Nobel lecture summarizing discovery)
• Armanios, Mary & Carol Greider. “Telomerase and Cancer Stem Cells.” Cold Spring Harb. Symp. Quant. Biol. 73: 333–338, 2008. (Telomere shortening limits cellular lifespan)
• Jaskelioff, Mariela et al. “Telomerase Reactivation Reverses Tissue Degeneration.” Nature 469(7328): 102–106, 2011. (Restoring telomerase reverses aging phenotypes in mice)
• Sahin, Ergun & Ronald A. DePinho. “Telomere Dysfunction in Aging and Disease.” Cell 152(2): 390–393, 2013. (How telomere shortening triggers DNA damage responses)
• Harley, Calvin B. et al. “Telomere Shortening Correlates with Cell Division.” Nature 345(6274): 458–460, 1990. (Classic study first correlating telomere length with replicative capacity)